Carboplatin

You have access
Pretreatment Platelet Count and Neutrophil/Lymphocyte Ratio Are Predictive Markers for Carboplatin Plus Pemetrexed Therapy-induced Thrombocytopenia
MASAYA TAKAHASHI, KATSUYUKI TAKAHASHI, HIROYASU KANEDA, TOMOYA KAWAGUCHI and KATSUYA NAGAYAMA

Anticancer Research November 2021, 41 (11) 5729-5737; DOI: https://doi.org/10.21873/anticanres.15389
You have access
Serum Proteomic Profiling Reveals Differentially Expressed IGHG3 and A1AG1 as Potential Predictors of Chemotherapeutic Response in Advanced Non-small Cell Lung Cancer
MAY MYAT MON, CHANTRAGAN SRISOMSAP, DARANEE CHOKCHAICHAMNANKIT, KAMOLWAN WATCHARATANYATIP, CHURAT WEERAPHAN, JISNUSON SVASTI, KAJORNKIAT MANEECHAI, PARAMEE THONGSUKSAI and PRITSANA RAUNGRUT

Anticancer Research April 2021, 41 (4) 1871-1882; DOI: https://doi.org/10.21873/anticanres.14953
You have access
Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Ovarian Cancer Cells In Vitro
TEA KUITTINEN, PÄIVI ROVIO, TIINA LUUKKAALA, MARITA LAURILA, SEIJA GRÉNMAN, ANNE KALLIONIEMI and JOHANNA MÄENPÄÄ

Anticancer Research June 2020, 40 (6) 3129-3138; DOI: https://doi.org/10.21873/anticanres.14294
You have access
Impact of Bevacizumab-containing Primary Treatment on Outcome of Recurrent Ovarian Cancer: An Italian Study
ANGIOLO GADDUCCI, STEFANIA COSIO, ANDREA ALBERTO LISSONI, VALENTINA ZIZIOLI, MARCO ADORNI, ANNA MARIA FERRERO, FABIO LANDONI and ENRICO SARTORI

Anticancer Research March 2020, 40 (3) 1543-1550; DOI: https://doi.org/10.21873/anticanres.14100
You have access
Carboplatin Plus Nab-paclitaxel in Performance Status 2 Patients With Advanced Non-small-cell Lung Cancer
KAZUHISA NAKASHIMA, HIROAKI AKAMATSU, HARUYASU MURAKAMI, TAKASHI NIWA, YASUO IWAMOTO, YUICHI OZAWA, TOSHIHIDE YOKOYAMA, HIROYASU SHODA, NOBUYUKI YAMAMOTO, HIROSHIGE YOSHIOKA, KEN MASUDA, TATEAKI NAITO, KEITA MORI and TOSHIAKI TAKAHASHI

Anticancer Research March 2019, 39 (3) 1463-1468; DOI: https://doi.org/10.21873/anticanres.13263
You have access
TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
AKIRA TAKEUCHI, TETSUYA OGURI, YORIKO YAMASHITA, KAZUKI SONE, SATOSHI FUKUDA, OSAMU TAKAKUWA, TAKEHIRO UEMURA, KEN MAENO, KENSUKE FUKUMITSU, YOSHIHIRO KANEMITSU, HIROTSUGU OHKUBO, MASAYA TAKEMURA, YUTAKA ITO and AKIO NIIMI

Anticancer Research September 2018, 38 (9) 5489-5495; DOI: https://doi.org/10.21873/anticanres.12882
You have access
Phase I Study Evaluating the Combination of Afatinib with Carboplatin and Pemetrexed After First-line EGFR-TKIs
SATOSHI WATANABE, OU YAMAGUCHI, AI MASUMOTO, YURI MAENO, YOSUKE KAWASHIMA, OSAMU ISHIMOTO, SHUNICHI SUGAWARA, HIROHISA YOSHIZAWA, TOSHIAKI KIKUCHI, TOSHIHIRO NUKIWA and KUNIHIKO KOBAYASHI

Anticancer Research August 2018, 38 (8) 4699-4704; DOI: https://doi.org/10.21873/anticanres.12776
You have access
Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
HIROAKI TAKEOKA, KAZUHIKO YAMADA, YOSHIKO NAITO, NORIKAZU MATSUO, HIDENOBU ISHII, TAKAAKI TOKITO, KOICHI AZUMA, MASAO ICHIKI and TOMOAKI HOSHINO

Anticancer Research June 2018, 38 (6) 3779-3784; DOI: https://doi.org/10.21873/anticanres.12661
You have access
Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells In Vitro
TEA KUITTINEN, PÄIVI ROVIO, SYNNÖVE STAFF, TIINA LUUKKAALA, ANNE KALLIONIEMI, SEIJA GRÉNMAN, MARITA LAURILA and JOHANNA MÄENPÄÄ

Anticancer Research December 2017, 37 (12) 6575-6581;
You have access
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility
GIOVANNI SCHINZARI, SANTA MONTERISI, FRANCESCO PIERCONTI, GIULIA NAZZICONE, LAURA MARANDINO, ARMANDO ORLANDI, MARCO RACIOPPI, ALESSANDRA CASSANO, PIERFRANCESCO BASSI, CARLO BARONE and ERNESTO ROSSI

Anticancer Research November 2017, 37 (11) 6453-6458;

Main menu

User menu

Search

Carboplatin

Pages